Yang Zhan, Ph.D.

Senior Program Manager at Inmagene Biopharmaceuticals
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Shanghai, China, CN

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Senior Program Manager
      • May 2020 - Present

    • China
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Program Manager
      • Oct 2017 - Dec 2019

      • Designed overall strategy and direction of preclinical and early clinical trials to meet regulatory requirements, ultimately to meet the project needs for clients; • Supervised and monitored multiple disciplinary activities for sponsors including pharmacology, DMPK, Toxicology studies, CMC, regulatory writing and IND submission within expected timeline; • Defined scope of work and generated timeline for the IND enabling project while working closely with the client and internal project team. • Kept clients and project team updated in a timely manner regarding progress of projects and decision points to facilitate the project development through regular teleconferences, e-mails, site visits or other suitable means. • Prepared the regulatory submission documents and dossier writing for pharmacology, DMPK and safety assessment parts. • Identified potential issues and input the constructive suggestions. Show less

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Scientist
      • Jul 2015 - Sep 2017

      • Led the optimization stage in drug discovery of small-molecule projects. • Directed biology and DMPK groups to design and improve the profiles of small molecules for selection of high-quality preclinical candidates. • Independently designed structures of biologically active molecules to conduct SAR studies. • Managed the external chemistry team (CRO, 15 FTEs) in the synthesis and characterization of drug candidates. • Coordinated with the computational chemistry group to develop structure-based modifications. • Skilled in scientific instrument [analysis and spectroscopic techniques (NMR, HPLC/UPLC, MS, LC-MS, IR, UV); structure-based modification software: MOE, Schrödinger] • GSK Exceptional Science Award Show less

Education

  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    Doctor of Philosophy (Ph.D.), Medicinal and Pharmaceutical Chemistry
    2010 - 2015
  • China Pharmaceutical University
    Bachelor's degree, Life science and technology
    2006 - 2010

Community

You need to have a working account to view this content. Click here to join now